GLP-2 TR

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, specifically formulated for metabolic optimization, adiposity research, and glucose regulation.

Primary Functional Benefits & Research Applications

• Targeted Fat Reduction & Weight Management: Stimulates dual receptor pathways to significantly enhance lipolysis and visceral fat reduction.
• Enhanced Satiety & Caloric Modulation: Delays gastric emptying and modulates central appetite signals for sustained caloric reduction.
• Glycemic Control & Insulin Secretion: Optimizes postprandial glucose uptake and restores physiological beta-cell response.
• Cardiometabolic Health Support: Favors blood pressure normalization and improvement in lipid panel markers.

All orders ship with thermally monitored packaging to preserve product integrity in transit.

Store lyophilized vials between 2°C and 8°C for short-term handling, or frozen at -20°C for long-term preservation.